Health Care/Hospital

Guo Guangchang's New Year's Message: Steer Through the Rapids, Believe in the Future

HONG KONG, Jan. 3, 2024 /PRNewswire/ -- In the blink of an eye, 2023 is coming to an end. Thank you for your hard work and dedication. It has been a year of relentless efforts toward hope. After experiencing the three-year epidemic, many families have made plans for the new year from the beginni...

2024-01-03 11:35 5610

Bangkok Dusit Medical Services strengthens partnership with CNN focusing on global health issues and solutions

HONG KONG, Jan. 3, 2024 /PRNewswire/ -- Bangkok Dusit Medical Services Public Company Limited (BDMS), the largest private healthcare network inThailand, is continuing its long-term partnership with CNN International Commercial (CNNIC) through the sponsorship ofVital Signs

2024-01-03 11:30 1971

Sciwind Biosciences Announces Positive Topline Results from Phase 3 Clinical Trial of Ecnoglutide (XW003), a Long-acting cAMP Signaling Biased GLP-1 Analog, in Adult Patients with Type 2 Diabetes in China

* Study participants receiving 0.6 and 1.2 mg ecnoglutide once weekly for 24 weeks achieved HbA1c reductions of 1.96 and 2.43% from baseline, respectively, compared to 0.87 % for placebo * In the 1.2 mg ecnoglutide cohort, 76.1% of participants achieved HbA1c ≤  6.5% and 35.2% achieved HbA1c< ...

2024-01-03 10:00 1882

WuXi XDC Enters into Partnership Agreement with IntoCell, Enabling Clients to Accelerate ADC Discovery and Development

SHANGHAI, Jan. 2, 2024 /PRNewswire/ -- WuXi XDC, a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADC and the other types of bioconjugate market, and IntoCell, a Korean biotechnology company dedicated to developing novel ADC platform technologies, ...

2024-01-03 09:28 1422

USANA Named No. 1 Vitamins and Dietary Supplements Brand in Philippines

Euromonitor honors USANA Philippines for fifth time MANILA, Philippines, Jan. 3, 2024 /PRNewswire/ -- USANA Health Sciences, Inc., a leader in the health and wellness industry, was named the number one vitamin and dietary supplement brand in Philippines* by Euromonitor. This marks the fifth tim...

2024-01-03 09:07 1518

Meihua International Medical Technologies Co., Ltd. Announces Closing of Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering

YANGZHOU, China, Jan. 2, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, today announced the closing of i...

2024-01-03 06:19 4228

Innovative Smart Sports and Digital Health Tech From ITRI Debut at CES 2024

LAS VEGAS, Jan. 2, 2024 /PRNewswire/ -- The Industrial Technology Research Institute (ITRI) , Taiwan's largest and one of the world's leading high-tech applied research institutions, today announced the introduction of smart sports and digital health innovations atCES 20...

2024-01-02 22:00 1671

Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca

NATICK, Mass., Jan. 2, 2024 /PRNewswire/ -- Allorion Therapeutics ("Allorion"), a US andChina-based biotechnology company that focuses on the discovery of new small molecule drugs for treating cancer and autoimmune diseases, has entered into an exclusive option and global license agreement with A...

2024-01-02 22:00 1543

MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to develop next-generation antibody drug conjugate in Oncology

SUZHOU, China, Jan. 2, 2024 /PRNewswire/ -- MediLink Therapeutics ("MediLink"), announced today that it has entered into a worldwide collaboration and license agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY) on the development of a next-generation antibody-drug conjugate candidate YL211, targeti...

2024-01-02 22:00 1431

Novel Device Facilitates Successful No-Shave FUE Transplants for Long Hair with Ease

LOS ANGELES, Jan. 2, 2024 /PRNewswire/ -- A recent study published in the Clinical, Cosmetic and Investigational Dermatology journal reveals a groundbreaking advancement in hair transplantation, reports Dr U Hair and Skin Clinic. The research, titled "No-Shave Long Hair Follicular Unit Excision u...

2024-01-02 21:00 1517

JJ's House Joins Forces with Sisters in the Fight Breast Cancer Foundation to Make Survivors Feel Beautiful

NEW YORK, Jan. 2, 2024 /PRNewswire/ -- JJ's House, the renowned global online retailer specializing in wedding, occasion, prom, and party dresses, proudly announces its partnership with the Sisters in the Fight Breast Cancer Foundation, aTexas-based charity dedicated to empowering breast cancer ...

2024-01-02 21:00 1187

YolTech Therapeutics to Present and Unveil Major Progress at Biotech Showcase 2024

SHANGHAI, Jan. 2, 2024 /PRNewswire/ -- YolTech Therapeutics, a biotech company developingin vivo gene editing therapies to treat rare genetic diseases, recently announced that it will present an overview of its technology and provide corporate updates on key programs at Biotech Showcase, taking p...

2024-01-02 20:30 1215

Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval

SHANGHAI, Jan. 2, 2024 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), recently announced that it has successfully obtained Humanitarian Use Device (HUD) designation from the US FDA and approval ...

2024-01-02 20:30 1739

JW Therapeutics Announces Exclusive Collaboration with 2seventy bio for Autoimmune Disease CAR-T Therapy

SHANGHAI, Jan. 2, 2024 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, is pleased to announce an exclusive collaboration with 2seventy bio (NASDAQ: TSVT), for the c...

2024-01-02 20:15 1925

Gannex Announces Positive Interim Results from 52-Week Phase II Clinical Trial of Once-Daily ASC41 Tablet in Patients with Biopsy-Confirmed Non-alcoholic Steatohepatitis

--Up to 68.2% mean relative reduction in liver fat content from baseline in biopsy-confirmed non-alcoholic steatohepatitis (NASH) patients receiving 12-week treatment of ASC41 tablet --At Week 12, up to 93.3% patients achieved at least a 30% relative reduction in liver fat content from baseline ...

2024-01-02 20:06 1758

Mabwell to attend 42nd JP Morgan Healthcare Conference and present at Biotech Showcase

SHANGHAI, Jan. 2, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that Dr.Hai Wu, President of R&D of Mabwell, will attend 42nd JP Morgan Healthcare Conference and present at Biotech Showcase in San Francisco, United State...

2024-01-02 17:15 1456

AXA enhances multiple employee benefits to promote work-life balance in the workplace

Paid co-parent leave significantly increased to 40 days with additional days paid caregiver and fertility leave, providing support to employees at different life stages HONG KONG, Jan. 2, 2024 /PRNewswire/ -- AXA has always advocated for a diverse and inclusive corporate culture and is committed...

2024-01-02 12:14 2650

Ascentage Pharma to Present at 42nd J.P. Morgan Healthcare Conference

SUZHOU, China and ROCKVILLE, Md., Jan. 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it will attend the 42nd J.P. Morgan Healthcare ...

2024-01-02 11:58 1653

Xinhua Silk Road: Xinhua-Yushu Wild Cordyceps Sinensis Price Index unveiled in Beijing

BEIJING, Jan. 2, 2024 /PRNewswire/ -- The Xinhua-Yushu Wild Cordyceps Sinensis Price Index was officially released on Dec. 27th inBeijing, capital of China, indicating the accelerated development of wild cordyceps sinensis industry towards a new stage of digital, information and modern mode.

2024-01-02 10:06 2001

Demron by RST - Advanced Protection Against Today's Nuclear Threats

MIAMI, Jan. 2, 2024 /PRNewswire/ -- Radiation Shield Technologies (RST) proudly marks over two decades of innovation with Demron, a unique fabric designed to safeguard frontline personnel, including military, nuclear industry workers, emergency response teams, Hazmat Teams, firefighters, law enfo...

2024-01-02 08:00 1666
1 ... 45464748495051 ... 807